Richard Rothman, MD
Hospital Medicine
Highlights
Age Groups Seen
- Adult
Languages
- English
Gender
MaleAbout Richard Rothman
Title
Vice President and Chief Medical Officer, Cleveland Clinic Indian River Hospital
Biography
Richard Rothman is the Vice President and Chief Medical Officer at Cleveland Clinic Indian River Hospital. In this role, Dr. Rothman leads the hospital’s strategic direction, development and performance and spearheads quality improvement projects.
Previously, Dr. Rothman was Regional Chief Medical Operations Officer for Cleveland Clinic Florida and the Florida Market leader of the Integrated Hospital Care Institute for Cleveland Clinic. As Regional Chief Medical Operations Officer for Cleveland Clinic Florida and the Florida Market leader of the Integrated Hospital Care Institute for Cleveland Clinic, Dr. Richard Rothman is one of the founders of Cleveland Clinic Hospital Care at Home. He graduated from St. George’s University School of Medicine in 2009 and did a post-doctoral research fellowship at the Massachusetts General Hospital in Boston, Ma. He completed both his internship and residency at the Lahey Clinic, also in Massachusetts. He has his diplomate in Internal Medicine from the American Board of Internal Medicine and is an active member of the American College of Physicians and Society of Hospital Medicine.
Citation Bibliography:
- Rothman RD, Delaney CP, Heaton BM, Hohman JA. Early experience and lessons following the implementation of a Hospital-at-Home program. Journal of hospital medicine. 2024. doi: 10.1002/jhm.13293
- Rothman RD and Delaney, CP. Hospital Care at Home: How Cleveland Clinic reimagined acute hospital care delivery. Becker's Hospital Review: Leadership and Management. 2024.
- Rothman RD, Peter DJ, Harte BJ. Improving Healthcare Value: Managing Length of Stay and Improving the Hospital Medicine Value Proposition. Journal of hospital medicine. 2021;16:620-622. doi: 10.12788/jhm.3662
- Rothman RD, Whinney CM, Pappas MA, Zoller DM, Rosencrance JG, Peter DJ. The relationship between the follow-up to discharge ratio and length of stay. Am J Manag Care. 2020;26:396-399. doi: 10.37765/ajmc.2020.88490
- McCullough SA, Shimada YJ, Baggish AL, Lowry PA, O’Callaghan C, Rothman RD, Vlahakes GJ, Fifer MA. Abstract 12390: Right Heart Failure Predicts Higher Mortality in Patients With Hypertrophic Cardiomyopathy. Circulation. 2014;130:A12390-A12390.
- Shimada YJ, Passeri JJ, Baggish AL, O'Callaghan C, Lowry PA, Yannekis G, Abbara S, Ghoshhajra BB, Rothman RD, Ho CY, et al. Effects of losartan on left ventricular hypertrophy and fibrosis in patients with nonobstructive hypertrophic cardiomyopathy. JACC Heart failure. 2013;1:480-487. doi: 10.1016/j.jchf.2013.09.001
- Iqtidar AF, Jeon C, Rothman R, Snead R, Pyne CT. Reduction in operator radiation exposure during transradial catheterization and intervention using a simple lead drape. American Heart Journal. 2013;165:293-298. doi: 10.1016/j.ahj.2012.10.002
- Shkolnik LE, Shin RD, Brabeck DM, Rothman RD. Symptomatic gastric sarcoidosis in a patient with pulmonary sarcoidosis in remission. BMJ case reports. 2012;2012. doi: 10.1136/bcr-2012-006559
- Rothman RD, Baggish AL, O'Callaghan C, Lowry PA, Bhatt AB, MacRae CA, Yannekis G, Sanborn DM, Mela T, Yeh RW, et al. Management strategy in 249 consecutive patients with obstructive hypertrophic cardiomyopathy referred to a dedicated program. The American journal of cardiology. 2012;110:1169-1174. doi: 10.1016/j.amjcard.2012.05.056
- Rothman RD, Weiner RB, Pope H, Kanayama G, Hutter AM, Jr., Fifer MA, Dec GW, Jr., Baggish AL. Anabolic androgenic steroid induced myocardial toxicity: an evolving problem in an ageing population. BMJ case reports. 2011;2011. doi: 10.1136/bcr.05.2011.4280
- Rothman RD, Safiia MA, Lowry PA, Mela T, Abbara S, O’Callaghan C, Mark EJ, Vlahakes GJ, Fifer MA. Risk stratification for sudden cardiac death after septal myectomy. Journal of Cardiology Cases. 2011;3:e65-e67. doi: 10.1016/j.jccase.2010.12.002
- Rothman RD, Safiia MA, Lowry PA, Mela T, Abbara S, O'Callaghan C, Mark EJ, Vlahakes GJ, Fifer MA. Risk stratification for sudden cardiac death after septal myectomy. J Cardiol Cases. 2011;3:e65-e67. doi: 10.1016/j.jccase.2010.12.002
- Rothman RD, Delaney CP, Heaton BM, Hohman JA. Early experience and lessons following the implementation of a Hospital-at-Home program. Journal of hospital medicine.n/a. doi: https://doi.org/10.1002/jhm.13293
Education & Board Certifications
Education
- Residency: Lahey Clinic Medical Center (Massachusetts), 2013
- Internship: Lahey Clinic Medical Center (Massachusetts), 2011
- Medical Education: St Georges School of Medicine (Grenada), 2009
Board Certifications
- Internal Medicine: American Board of Internal Medicine, 2014
Research & Publications
See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.
As of 2025-01-28, Dr. Rothman has reported the financial relationships with the companies listed below.
Consulting and/or Speaking. Dr. Rothman receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:
- Medically Home Group, Inc.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.